Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Men over 50 often experience urinary issues due to prostate enlargement or bladder problems, treatable with therapies, medications, or surgery.

Different botulinum toxin products and concentrations can effectively reduce sweating, itching, bladder pressure, hair loss, and muscle spasms.

Tamsulosin and solifenacin together effectively reduce symptoms in BPH patients.

Early intervention for acute urinary retention can reduce costs and improve care.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

The lowest effective dose of Botox for detrusor sphincter dyssynergia is between 75-100 units.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Unexplained anemia in older men may be linked to urological issues like urinary retention.

Cutaneous vesicostomy and cystoscopic valve ablation both have pros and cons for managing posterior urethral valves.

Botulinum toxin is used in many medical fields beyond cosmetic purposes.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Cancer prevention has advanced significantly, with some strategies proving successful.

African plum is linked to treating BPH and has economic benefits.

Desmocollin 1 and 3 have distinct patterns in human tissues, with Dsc1 in specific skin and hair layers and Dsc3 in various epithelial layers.

Selenium supplements do not prevent cancer and may have harmful effects.

Involucrin is a useful marker for keratinocyte differentiation in mice.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

SV40 T antigen in hair follicles causes abnormal hair and health issues in mice.

Early detection and treatment of urinary symptoms can help maintain functional ability in older adults.

Keratin hydrogel from human hair helps rats recover better from spinal cord injuries.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Anxiety from bedwetting caused a boy to pull out his eyelashes, but it was resolved with family and school support.

Venlafaxine can cause urinary incontinence in rare cases.

Older patients sticking to their prostate medication saw lasting health benefits.

Organoids created from stem cells are used to model diseases, test drugs, and develop personalized and regenerative medicine.